Nile Pharmaceuticals and Chemical Industries provided earnings guidance for the year 2020. The company expecting to achieve a net-profit-before-tax of EGP 153.7 million in the fiscal year 2020/2021. Revenue is expected to reach EGP 1.1 billion in FY20/21, compared to EGP 740 million in FY19/20.